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Poliomyelitis, also known as polio, is a highly infectious viral disease, predominantly affecting children under five years old. The virus 
is transmitted from person-to-person and mainly spreads 
through the fecal-oral route. The virus multiplies in the 
intestine, from where it can invade the nervous system 
via the bloodstream, potentially causing paralysis. Polio 
symptoms include fever, fatigue, headache, vomiting, 
neck stiffness and pain in the limbs. The disease causes 
permanent paralysis in one out of 200 infections. 
Currently, there is no cure for polio; it can only be 
prevented by immunisation.1
Past Global Successes
In 1988, the World Health Assembly declared its commit- 
ment to eradicate wild poliovirus (WPV), which had 
been reported in 125 endemic countries. Since then, 
there has been a decline of over 99% of cases globally, 
from an estimated 350,000 cases in 1988 to 33 reported 
cases by the end of 2018 [Figure 1]. A number of the 
World Health Organization (WHO) regions have been 
certified polio-free for many years, namely the Americas 
(1994), the Western Pacific region (2000), the European 
region (2002) and the South-East Asian region (2014). 
To date, no WPV type 1 cases have been reported in 
the African region in more than 41 months. This achieve- 
ment marks a significant step towards global eradication 
of WPV, with 80% of the world’s population now living 
in certified polio-free regions.2 The WHO estimated 
that 1.5 million childhood deaths have been prevented 
and more than 18 million people, who would have been 
paralysed, are able to walk today due to systematic polio 
immunisation activities. In addition, the eradication of 
WPV would save at least $40–50 billion USD, mostly 
in low-income countries.1
Current Failures
There are three strains of WPV (i.e. type 1, type 2 
and type 3). The trivalent oral polio vaccine (tOPV) 
induced a high type 2 sero-conversion rate;3 hence, 
transmission was easily and quickly interrupted and 
type 2 was eradicated globally by 1999.4 Meanwhile, 
a bivalent OPV for type 1 and 3 was introduced, 
which showed superiority over the tOPV and higher 
immunogenicity to type 3;5 global eradication of type 
3 was officially announced in October 2019 [Figure 1].6 
Despite achieving the eradication of types 2 and 3 and a 
reduction by over 90% in the prevalence of type 1 since 
2014, child paralysis from WPV type 1 infections was 
still evident in two remaining endemic countries.2 
The remaining two countries with reported ongoing 
WPV type 1 transmission are Afghanistan and Pakistan, 
which harbour the only global reservoir of WPV type 
1.7,8 Since early 2019, WPV cases from Pakistan have 
increased dramatically. This followed an 18-month 
period from January 2017 to mid-2018 in which 
Pakistan had achieved the lowest number of WPV 
type 1 cases in its previous 10 years, including several 
months without a single reported case. Globally, the 
annual number of WPV type 1 cases was 22 in 2017 
and 33 cases in 2018, indicating a missed opportunity 
for halting WPV transmission.7,8
As of 21st December 2019, the reported cases of 
WPV type 1 in Pakistan has risen to 111, representing 
80% of the global WPV cases; 44% of the environmental 
samples collected have been positive for WPV type 1, 
indicating widespread virus circulation across the 
country.9 In addition, there are reported exports of the 
virus to Iran, with Pakistan-linked WPV type 1 isolated 
from an environmental sewage sample collected on 20th 
April 2019 in the Konarak district, Sistan-Baluchistan 
province, Iran. However, no associated cases of para- 
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lysis have been found.10 Meanwhile, Afghanistan has 
reported 26 cases of WPV type 1 as of 21st December 
2019.10,11 Endemic transmission of WPV continues in 
border areas of Afghanistan and Pakistan.7 The main 
factors attributed to the current outbreak are issues related 
to coordination and implementation of vaccine delivery 
and unresolved issues with campaign quality, monitoring, 
accountability and community engagement.4,6,8
The surge in polio cases in 2019 has threatened the 
goal of its global eradication. Until WPV transmission 
is interrupted in these countries, all countries remain 
at risk of WPV importation, especially vulnerable 
countries with weak public health systems, suboptimal 
immunisation services and travel or trade links to 
endemic countries. As per global estimation, failure to 
eradicate WPV could result in as much as 200,000 new 
WPV cases yearly in the next 10 years. Therefore, it is 
vital to ensure WPV is globally eradicated.1,2 Herein we 
highlight the lessons learnt to date and propose steps 
to reach eradication.
How to Set it Right
The global polio eradication strategic plan identified 
five priority strategic interventions which included: 1) 
high levels of routine immunisation; 2) supplementary 
immunisation activities (SIA; target coverage above 
95%); 3) acute flaccid paralysis (AFP) surveillance 
(target = 2/100,000 among those aged ≤15 years); 
4) mop-up campaigns (if required); and 5) care for 
post-polio paralysis.12 Failure to implement strategic 
approaches leads to risk of either unidentified imported 
cases or a dangerous delay in responding to WPV 
importation.
In Oman, the last major WPV outbreak was 
caused by the type 1 strain in 1988–89. The last two 
cases of WPV were reported in 2005 in Yemen and 
had type 1 WPV [Figure 2].13,14 Over the years, Oman 
has implemented some important components of the 
polio eradication strategies such as ensuring that the 
third dose of the oral polio vaccine (OPV3) coverage is 
>95% through routine immunisation services among 
infants aged <1 year. This has been maintained for 
more than a decade.15 Additionally, polio SIA were 
implemented from 1995–99 and again in 2005. AFP 
surveillance was launched in 1993 and since then the 
rate of non-polio AFP has remained above 2/100,000 
people among those aged ≤15 years, with adequate testing 
of stool specimens above 80%.15,16 The performance 
of AFP surveillance is assessed through the annual 
detection rate of non-polio AFP recommended by the 
WHO. The AFP rates in Oman have been in constant 
decline, from 4.5 to 3.2 to 2.8 cases per 100,000 people 
aged <15 years in 2017, 2018 and 2019, respectively.17 
Sensitive surveillance is the gold standard of polio 
eradication and the only tool to identify importation.1,11 
These rates have so far been considered sensitive 
enough to detect a case of WPV. The second perf- 
ormance indicator is the collection of adequate stool 
specimens (i.e. two stool specimens collected >24 
hours apart, within 14 days of paralysis onset and 
arrival at the laboratory in good condition from ≥80% 
of reported cases of AFP patients). These targets have 
also been successfully met in Oman.1,12
Recommendations
The risk of exportation of WPV type 1 to Oman exists. 
Apart from the geographical proximity of Oman to 
the endemic countries, there are also many individuals 
from endemic countries who frequently visit and 
have visitors from endemic countries. The population 
of expatriates (approximately 44% of the country’s 
total population) includes 219,901 (4%) Pakistanis.18 
Two essential pillars for preparedness against the 
importation of WPV includes robust AFP surveillance 
 
Figure 1: Globally reported wild poliovirus cases from 1972–2019.20
WPV = Wild poliovirus.
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and high population immunity among non-polio AFP 
and SIA.19
To prevent transmission of the virus across 
borders, early detection of the virus is critical and can 
be achieved by strengthening both active and passive 
AFP surveillance to identify potential AFP cases among 
Oman's residents. This would ensure that the entire 
population, whether residing or visiting Oman are 
vaccinated, as is appropriate for their specific age 
group, prior to entering the country. 
In addition, the polio programme has to establish 
standard protocols for the care and long-term follow-
up of post-polio paralysis patients, as well as ways to 
reduce the psychological and financial burdens on 
patients. An ongoing problem is the difficulty of keeping 
the polio vaccine stockpiled in Oman. Finally, proper 
attention should be given to rigorous evaluation of 
the national polio programme and its successes and 
failures should be shared with others.
To date, WPV type 1 transmission has not been 
interrupted in Afghanistan and Pakistan.4 The increasing 
WPV cases have secured the disease’s status as a global 
public health emergency and the global community 
has expressed concern over ongoing transmission 
in these countries. These two countries constitute 
one epidemiological block and must continue to be 
treated as such to achieve eradication. In order to 
end transmission of WPV1, complete population 
immunity must be achieved and doing so requires 
delivering polio vaccine to all children. Failure to 
eradicate polio would have major global repercussions. 
Importation of WPV cannot be prevented until global 
WPV eradication is attained making early detection of 
WPV in polio-free states a public health priority.
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Figure 2: Reported wild poliovirus cases and coverage of oral poliovirus vaccine 3 use in Oman from 1975–2019.15,20
OPV = oral polio vaccine; WPV = Wild poliovirus.
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